AI assistant
Bliss GVS Pharma Limited Earnings Release 2020
61284_rns_2019-08-14_b5ccd7fd-4daa-4002-9166-c346174fed09.pdf
Earnings Release
Open in viewerOpens in your device viewer
BLISS GVS PHARMA LTD.
August 14, 2019
| To | To |
|---|---|
| histiTMLDtmte,ganagerneparen | halistiTGMLDtmte,generanagerneparen |
| ioalSckhofdiNEInattonxcangea | SimitedBEL |
| /crGPlBlk,otnooc | PhiJeejbhToyrozeeeowers, |
| BdrKlaCleBdr(Et),aana-urompxanas, | DalalStrt,ee |
| bai400051M-um | Mbai400001-um |
| SbolBLISSGVS:ym | SiCod501976pe:cr |
Subject: Newspaper Advertisement of Unaudited Financial Results for the first quarter ended Tune 30, 2019
Dear SirIMadam,
Pursuant to the provisions of Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed herewith the extract copies of newspaper advertisement clippings of unaudited financial results of the Company for the first quarter ended June 30, 2019 published in 'The Economic Times & The Free Press Journal' an English Daily and 'Maharashtra Times & Navshkati' a Regional Daily, on August 14,2019.
Kindly take the same on record.
Thanking you,
Yours faithfully,
Encl: As above
Regd. Office: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400072, INDIA. TEL. : (+91) (22) 42160000/28505387 • FAX.: (+91) (22) 28563930, Email: [email protected] • Website: www.blissgvs.com • CIN - L24230MH1984PLC034771 Factory: Plot No. 10 & 11 Survey No. 38/1, Dewan Udyog Nagar, Aliyali Village, Tal. & Dist. Palghar - 401404. Tel. (+91) (02525) 252713 • Fax: (+91) (02525) 255257.' Email: [email protected]
'i' AUGUST "I' , WW.EGONOMIGTIMES"cciM :: 1,,1
B'LIS S' ,GVS PHARMA , LI,MITED CIN No.- L24230MH1984PLC034771 - ;"'E ";;'N OMIG TIMeS , MUM~AI , WEDNESOAY
Registered Office: 102, Hyde Park" Saki Vi,har Road, Andheri (t;:ast), Mumbai - 400 072, , " I , • Tel: 022-42160000·, FaX: 022-28563930 • Email: info@bnssgvs~com • Website: www.blissgvs.com
EXTRACT OF STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30,2019
| ." | \ | '- | in Lakhs)(f. | ||||
|---|---|---|---|---|---|---|---|
| STANDALONEI | CONSOLIDATED | ||||||
| ,?,;;1,. "I ~~~ ': "• !,":.,,*i'·t·Partila•curs- | QUARTERENDED30.06.2019(U)NAUDITED | QUARTER,ENDED31.03.2019(A)UDITED | YEARENDED31.03.2019(A)UDITED | QUARTERENDEDI,' 30.06.2019(UNAUDIT~D) | ,IQUARTERENDED31.03.2019(AUDITED | YEARENDED31~03.2019(A)UDITED | |
| Tolinfroio(n)taatetcomemoperns | 11,516.10 | 10,614.32 | 42,659.02 | 21,153.20 | 24,405.08I | 89,824.92 | |
| NeProfit/ (loss)froditivitieafttetamornaryacsrx | 2,391.95, | ,463.50 | ,7,443.39, | 3,379.07, | 1,810.76 | 12,372.16 | |
| Net Pfit/(lo)froditivitieafter trossmornaryacsax,iolddiitepttraexcenaanexornaryms | 2,391:95 | 463.50 | 7,443.39 | 3,379.07 | 1,810.76,- | 12,312.16 | |
| TolCehsivInfothriodtaomprenecomerepe | 2,391.30 | 441.26 | 7,426.03 | 3,444.08 | 1,825.71 | 12,222.20 | |
| EquitShCapitalyare | 1,031.47 | 1,031.47 | 1,031.47 | ' 1,031.47 | 1,(')31.47, | 1,031.47 | |
| OthEquitIery | - | - | , 59,295.89 | - | - | 63,568.39 | |
| ShEainPerngsrare | , | ' ' | - | ||||
| Bas'indDiluted(in),ca~.<br>.:. | ,2.32 | '<br>0.45 | ;.:;' 7.22: | 3.28" | 1.76 | 11.99" |
,Note: , ' ' ,
(1)The above is an extract of the detailed format of the Standalone and Consolidated financial resultsfor the Quarter ended' 30 June, 2019 and Quarterly and Annual Resultfor the Year ended March 31, 2019 are filed with the Stock Exchanges under Regulation 33 of'the SEBI (Listing Obligations andDisclosure Requirements)Regulati0ns,'2015, " ", '
Thefigures for the quarter ended Ma'rch31, 2019 arethe balancing figuesbetweenth!3audited figures in respect of the year ended Marc31, 2019 and unaudited figures in respectdfthe ninemonths ended December 31,2018. ,'" 1
(2)The full format of the Standaloneand Consolidated financial results for the Quarter ended June' 30, 2019 and Quarterly and Annual Resultfor the Yearended March31, 2019,areavailable on the Stock Exchangewebsites -www.bseindia.comand www.nseindia.com and on the Company'swebsite www.blissgvs.com, (3)The results havebeen prepared in accordance with the IndianAccountinq Standards (IndAS) as prescribed under section 133of the Companies Act read with relevantrules issuedthere under. 'I: '
--~~~~~--~~~~------------'------------------~-------------------------'--------_'
j Forand on behalf of the Board of Directors , SD/-
Place: Mumbai Date : August 12,2019 Narslmha Shibroor Kamath Managing Director •
, ..... _ www.freepressjournaUn 11-1 THE FREE PRESS JOVRNAL , MUMBAIIWEDNESDAY IAUGUST 14,2019
BLISS . · . ·YS '. PHARMA LIMITE D· CIN No.- L24230MH1984PLC034771
• -Tel: 022-42160000 • Fax: 022-28563930 • Email: [email protected] • Website: www.blissgvs.com
Registered Office: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072.
EXTRACT OF STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2019
| Q | UARTER | YEAR | QUARTER"QU~R'TER | ||||
|---|---|---|---|---|---|---|---|
| Partilacurs | QUARTERENDED-. 330.020196.(U)(ANAUDITED | ENDED1.03.201931)(AUDITED | ENDED. -.03.2019)(UUDITED | DENDE;-,30.02019'6..,:,~)'(ANAUDITED | ED-END1k(P.2Q19',3.(AEDUDIT | YEARENDED1.03.2019)UDITED | |
| fro(n)talinatioetcomernoperns+++.-------------------of/(Ls)froaftPritditivitietetaosmornaacsrx | 11;516.10++-----2,391.95 | 10,614.32+------463.50' | 42,659.027,443.39 | 21,153.203,379.07 | 24,405.081,810.76 | 89,824.912,372.1f | |
| ryProfit/(Ls)froditivitieafttetaosmornaacsr | 2,391.95 | 463.50 | 7,443.39 | 3,379.07 | I1,810.76 | 12,372.1 | |
| ryx,iolddiitepttracenaanexornarymsl CehsivInfothriodtaomprenecomerepe | 2,391.30 | 441.26 | 7,426.03 | 3,444.08 | $1,82715.~ | 1~,222.: | |
| ShCauital.' | 1,031.47 | 1,031.47 | 1,031.47 | 1,031.47 | i1,031.47 | 1,031.' | |
| pityarethuit | 59,295.89 | 63,568.: | |||||
| EqeryinPeS.harnrre | |||||||
| gsBasicndDiluted | 2.32 | 0.45 | 227. | 3.28 | 1.76 | 11 | |
| (in):a~. |
(1)The above is an extract of the detailed tormat of the Standalone and Consolidated financiatresults for the Quarter ended 30 June , 29.{g and Quarte
and AnnuaJ.-Resultfor the Yearended March 31, 2019 are filed with the Stock Exchanges under.Regulation 33 of the SEBI (Listing Obligations and Disclos . . , Requirements) Regulations,2015. " ", Thefigures for the quarter ended March 31, 2019 are the balancing figures between the audited figures in respect ofthe year ended March 31, 20;'9 anct~'naudi
figures'in respectoflhe nine months ended December 31,2018. . . . .'~. (2).Thefull format of the Standalone and Consolidated financial results for the Quarter ended June 30,2019 and Quarterly and Annual Resultfor the y'~~rern
For and on behalf of the Board ofDirect, March31,2019 are availableon the Stock Exchangewebsites - www.bseindia.com and www.nselndla.corrfand onthe Company'swebsite www.blissgvS(com. (3)the r~ Its have been prepared in accordance with the IndianAccountinqStandards (Ind AS) as'prescribed under section 133ofthe Companies Act read, relevantr . sued there under. . ,; ~
Date : August 12, 2019
Place: Mumbai
SD/- - Narslmha Shlbroor K~~atl:l Managing Direct!;»r. '~:, r
(~in Lakhs)
मंबड़े । बधवार. t mumbai.mtonline.in १४ आगस्ट २०१९
प्रतिक्रियेसाठी mtantare a gmail.com । महाराष्ट्र टाइम्स
BLISS GVS PHARM CIN No. - L24230MH1984PLC034771
Registered Office: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072. · Tel: 022-42160000 · Fax: 022-28563930 · Email: [email protected] · Website: www.blissgvs.com
EXTRACT OF STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2019
| $(5 \text{ in Lakhs})$ | |||||||
|---|---|---|---|---|---|---|---|
| STANDALONE | CONSOLIDATED | ||||||
| Briss-Pario (10-5Particulars | QUARTERENDED30.06.2019(UNAUDITED) | QUARTERENDED31.03.2019(AUDITED) | YEARENDED31.03.2019(AUDITED) | QUARTERENDED30.06.2019(UNAUDITED) | QUARTERENDED31.03.2019(AUDITED | YEARENDED31.03.2019(AUDITED) | |
| Total income from operations (net) | 11,516.10 | 10,614.32 | 42,659.02 | 21,153.20 | 24,405.08 | 89,824.92 | |
| Net Profit / (Loss) from ordinary activities after tax | 2,391.95 | 463.50 | 7,443.39 | 3,379.07 | 1,810.76 | 12,372.16 | |
| Net Profit / (Loss) from ordinary activities after tax,exceptional and extraordinary items | 2,391.95 | 463.50 | 7,443.39 | 3,379.07 | 1,810.76 | 12,372.16 | |
| Total Comprehensive Income for the period | 2,391.30 | 441.26 | 7,426.03 | 3,444.08 | 1,825.71 | 12,222.20 | |
| Equity Share Capital | 1,031.47 | 1,031.47 | 1,031.47 | 1,031.47 | 1,031.47 | 1,031.47 | |
| Other Equity | 59,295.89 | $\frac{1}{2}$ | 63,568.39 | ||||
| $-15$F FillEarnings Per Share | |||||||
| Basic and Diluted (in $\bar{z}$ .) | 2.32 | 0.45 | 7.22 | 3.28 | 1.76 | 11.9 |
Note:
(1) The above is an extract of the detailed format of the Standalone and Consolidated financial results for the Quarter ended 30 June, 2019 and Quarterly and Annual Result for the Year ended March 31, 2019 are filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosur Requirements) Regulations, 2015.
The figures for the quarter ended March 31, 2019 are the balancing figures between the audited figures in respect of the year ended March 31, 2019 and unaudite figures in respect of the nine months ended December 31, 2018.
(2) The full format of the Standalone and Consolidated financial results for the Quarter ended June 30, 2019 and Quarterly and Annual Result for the Year ender March 31, 2019 are available on the Stock Exchange websites - www.bseindia.com and www.nseindia.com and on the Company's website www.blissgvs.com. (3) The results have been prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under section 133 of the Companies Act read wit relevant rules issued there under.
For and on behalf of the Board of Director: $SD/-$
Place : Mumbai Date: August 12, 2019 Narsimha Shibroor Kamath Managing Director
BLISS GVS PHARMA LIMITED CIN No.- L24230MH1984PLC034771
Registered Office: 102, Hyde Park, Saki Vihar Road, Andheri (East), Mumbai - 400 072. · Tel: 022-42160000 · Fax: 022-28563930 · Email: [email protected] · Website: www.blissgvs.com
EXTRACT OF STATEMENT OF UNAUDITED STANDALONE AND CONSOLIDATED FINANCIAL RESULTS FOR THE QUARTER ENDED JUNE 30, 2019
| $($ in Lakhs) | |||||||
|---|---|---|---|---|---|---|---|
| Particulars | STANDALONE | CONSOLIDATED | |||||
| QUARTERENDED30.06.2019(UNAUDITED) | QUARTERENDED31.03.2019(AUDITED) | YEARENDED31.03.2019(AUDITED) | QUARTERENDED30.06.2019(UNAUDITED) | QUARTERENDED31.03.2019(AUDITED | YEARENDED31.03.2019(AUDITED) | ||
| Total income from operations (net) | 11,516.10 | 10,614.32 | 42,659.02 | 21,153.20 | 24,405.08 | 89,824.92 | |
| Net Profit / (Loss) from ordinary activities after tax | 2,391.95 | 463.50 | 7,443.39 | 3,379.07 | 1,810.76 | 12,372.16 | |
| Net Profit / (Loss) from ordinary activities after tax,exceptional and extraordinary items | 2,391.95 | 463.50 | 7,443.39 | 3,379.07 | 1,810.76 | 12,372.16 | |
| Total Comprehensive Income for the period | 2,391.30 | 441.26 | 7,426.03 | 3,444.08 | 1,825.71 | 12,222.20 | |
| Equity Share Capital | 1,031.47 | 1.031.47 | 1,031.47 | 1,031.47 | 1,031.47 | 1,031.47 | |
| Other Equity | 59,295.89 | 63,568.39 | |||||
| Earnings Per Share | |||||||
| Basic and Diluted (in $\bar{z}$ .) | 2.32 | 0.45 | 7.22 | 3.28 | 1.76 | 11.99 |
Note:
(1) The above is an extract of the detailed format of the Standalone and Consolidated financial results for the Quarter ended 30 June, 2019 and Quarterly and Annual Result for the Year ended March 31, 2019 are filed with the Stock Exchanges under Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The figures for the quarter ended March 31, 2019 are the balancing figures between the audited figures in respect of the year ended March 31, 2019 and unaudited figures in respect of the nine months ended December 31, 2018.
(2) The full format of the Standalone and Consolidated financial results for the Quarter ended June 30, 2019 and Quarterly and Annual Result for the Year ended March 31, 2019 are available on the Stock Exchange websites - www.bseindia.com and www.nseindia.com and on the Company's website www.blissgvs.com. (3) The results have been prepared in accordance with the Indian Accounting Standards (Ind AS) as prescribed under section 133 of the Companies Act read with relevant rules issued there under.
For and on behalf of the Board of Directors $SD/-$
Narsimha Shibroor Kamath Managing Director
Place: Mumbai Date: August 12, 2019